Benzinga - by Avi Kapoor, Benzinga Staff Writer. U.S. stock futures traded mixed this morning, with the Dow Jones futures falling around 70 points on Thursday. Shares of Sprinklr,...
Benzinga - by Lisa Levin, Benzinga Editor. U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday. Shares of Dell...
Benzinga - by Lisa Levin, Benzinga Editor. U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. Shares of La-Z-Boy Incorporated (NYSE:...
Benzinga - by Lisa Levin, Benzinga Editor. U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 40 points on Wednesday. Shares of DLocal...
MorphoSys AG (NASDAQ: MOR) released topline results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK...
Investing.com - MorphoSys ADR (NASDAQ: MOR) reported third quarter EPS of $-3.50, $2.92 worse than the analyst estimate of $-0.58. Revenue for the quarter came in at $63.8M...
Benzinga - by Lisa Levin, Benzinga Editor. Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to...
MorphoSys AG (MOR) today announced strong topline results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK...